Results 121 to 130 of about 92,190 (233)

Improvement in cutaneous disease with menin inhibitor monotherapy in KMT2A rearranged AML. [PDF]

Br J Haematol
Chadwick J, Rees-Unwin K, Anandhan V, Searle E.   +3 more
europepmc   +1 more source

Leveraging chromatin packing domains to target chemoevasion in vivo. [PDF]

Proc Natl Acad Sci U S A
Frederick J, Virk RKA, Ye IC, Almassalha LM, Wodarcyk GM, VanDerway D, Gong R, Dunton CL, Kuo T, Medina KI, Loxas M, Ahrendsen JT, Gursel DB, Gonzalez PC, Nap RJ, John S, Agrawal V, Anthony NM, Carinato J, Li WS, Kakkaramadam R, Jain S, Shahabi S, Ameer GA, Szleifer IG, Backman V.   +25 more
europepmc   +1 more source

Thinking outside the mouse: emerging vertebrate models in biomedicine. [PDF]

Biol Open
Ferreira-Gonzalez S, Çevrim Ç, Rodrigo Albors A.   +2 more
europepmc   +1 more source

The Biodiversity of Peter I Island-The Most Remote Island in the World. [PDF]

Ecol Evol
Jackson M, Clarkin E, Ryan C, Santangelo M, Stephenson B, Blakeslee M, Forbes S, Kirchner R, Searle Pineda A, Wolff A, Hart T.   +10 more
europepmc   +1 more source

Development of a Combined Clinical and Research-Developed Testing Strategy for Highly Pathogenic Avian Influenza A Virus H5. [PDF]

Open Forum Infect Dis
Adams GC, Devlin JE, Klontz E, Laing RA, Branda JA, Chowdhury N, Kwon S, Sabeti PC, Stachler E, Thiriveedhi V, Shenoy ES, Lemieux JE, Turbett SE.   +12 more
europepmc   +1 more source

John Searle: Making the Social World. The Structure of Human Civilization [PDF]

ontology, social institutions, social reality, commitment, speech act, social ...
Axel Buehler
core  

Learnings From the Front Line: Early Implementation Experiences of the Central Queensland Foot Hub Virtual Multidisciplinary Team Model-of-Care. [PDF]

Aust J Rural Health
Kumar S, Walker A, Leech C, Powell E, Varrall R, Ramsay S, Searle R, Jensen S.   +7 more
europepmc   +1 more source

Impacts of Selective Predation on Infection Prevalence and Host Susceptibility. [PDF]

Ecol Evol
Gutierrez SO, Bernal XE, Searle CL.
europepmc   +1 more source

A phase 1, first-in-human, dose-escalation study of JNJ-74856665 (dihydroorotate dehydrogenase inhibitor) alone or in combination in patients with AML or MDS. [PDF]

Br J Haematol
Searle E, Cluzeau T, O'Nions J, Recher C, Gyan E, Morillo D, Esteve J, Kulasekararaj A, Raffoux E, Walter HS, Pigneux A, Valcárcel D, Daskalakis N, Bussolari J, Pietsch EC, Kuduk S, Bush T, Zhang X, Philippar U, Oluwasanjo A, Bradford K, Miller J, Van Bogaert C, Curtis M, Chang SY, Guttke C, Gaj S, Pearson R, Murphy J, van Dijck W, Alfonso Piérola A.   +30 more
europepmc   +1 more source

John Searle

, 2019
openaire   +2 more sources